Genomes and Genes

Species

Nils Ewald

Summary

Affiliation: University of Giessen
Country: Germany

Publications

  1. Ewald N, Bretzel R. Diabetes mellitus secondary to pancreatic diseases (Type 3c)--are we neglecting an important disease?. Eur J Intern Med. 2013;24:203-6 pubmed publisher
    ..Since most patients with T3cDM suffer from chronic pancreatitis, physicians must additionally be aware of the elevated risk of pancreatic cancer in this subset of patients. ..
  2. Ewald N, Kaufmann C, Raspe A, Kloer H, Bretzel R, Hardt P. Prevalence of diabetes mellitus secondary to pancreatic diseases (type 3c). Diabetes Metab Res Rev. 2012;28:338-42 pubmed publisher
    ..Yet, the right classification of diabetes mellitus is important, because there are special therapeutic options and problems in patients with diabetes secondary to pancreatic diseases. ..
  3. request reprint
    Ewald N, Bretzel R, Fantus I, Hollenhorst M, Kloer H, Hardt P. Pancreatin therapy in patients with insulin-treated diabetes mellitus and exocrine pancreatic insufficiency according to low fecal elastase 1 concentrations. Results of a prospective multi-centre trial. Diabetes Metab Res Rev. 2007;23:386-91 pubmed
    ..Pancreatin therapy can be used safely in patients with diabetes mellitus and exocrine dysfunction. Parameters of glucose metabolism were not improved by enzyme replacement therapy. ..

Detail Information

Publications3

  1. Ewald N, Bretzel R. Diabetes mellitus secondary to pancreatic diseases (Type 3c)--are we neglecting an important disease?. Eur J Intern Med. 2013;24:203-6 pubmed publisher
    ..Since most patients with T3cDM suffer from chronic pancreatitis, physicians must additionally be aware of the elevated risk of pancreatic cancer in this subset of patients. ..
  2. Ewald N, Kaufmann C, Raspe A, Kloer H, Bretzel R, Hardt P. Prevalence of diabetes mellitus secondary to pancreatic diseases (type 3c). Diabetes Metab Res Rev. 2012;28:338-42 pubmed publisher
    ..Yet, the right classification of diabetes mellitus is important, because there are special therapeutic options and problems in patients with diabetes secondary to pancreatic diseases. ..
  3. request reprint
    Ewald N, Bretzel R, Fantus I, Hollenhorst M, Kloer H, Hardt P. Pancreatin therapy in patients with insulin-treated diabetes mellitus and exocrine pancreatic insufficiency according to low fecal elastase 1 concentrations. Results of a prospective multi-centre trial. Diabetes Metab Res Rev. 2007;23:386-91 pubmed
    ..Pancreatin therapy can be used safely in patients with diabetes mellitus and exocrine dysfunction. Parameters of glucose metabolism were not improved by enzyme replacement therapy. ..